Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.
Welcome back to the workweek. I, for one, have never been less excited to receive a flurry of texts from friends than I was Friday night, when we learned that Supreme Court Justice Ruth Bader Ginsburg had died at 87 of complications related to pancreatic cancer.
I'll be spending a lot of this week thinking about her legacy in healthcare and what might come next as the Supreme Court prepares to hear arguments related to the Affordable Care Act.
In healthcare news, we're already off to a busy start with the news that Illumina is acquiring its once-spinout Grail, a company focused on early cancer detection testing. Over the years, Grail has racked up more than $1.9 billion in funding from the likes of Jeff Bezos and Bill Gates and pharma giants like Merck. Prior to Illumina swooping in, Grail had recently filed to go public.
The CDC reversed course yet again, removing widely condemned language about not testing asymptomatic people for the coronavirus
Inside the murky world of Big Pharma's celebrity partnerships, where stars like Serena Williams and Khloe Kardashian get paid to promote prescription drugs
More stories we're reading:
Today is my dog's eighth birthday! I'll try to post a photo of him on Twitter to celebrate, so be sure to follow me there.
Do you have a personal experience with the coronavirus you'd like to share? Or a tip on how your town or community is handling the pandemic? Please email email@example.com and tell us your story.
Get the latest coronavirus business & economic impact analysis from Business Insider Intelligence on how COVID-19 is affecting industries.